Uncategorized Archives - Oncology Central Oncology Central

Must read

12 Oct 2018
Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Must watch

13 Feb 2019 Lung
Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

14 Nov 2018 Pancreatic
Emerging treatment options for pancreatic cancer with Thomas Seufferlein
14 Sep 2018 Breast
Tamoxifen, SERMs and sustainable medicine
14 Sep 2018 Immuno-oncology
Seven challenges in immuno-oncology
18 Jun 2018 Head and neck
The importance of a multidisciplinary team in the care of head and neck cancer

Stay up to date

Upcoming event

Gastrointestinal Cancers Symposium

January 17, 2019 – January 19, 2019

CA, USA

View all

Upcoming event

International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

February 9, 2019 – February 11, 2019

Kyoto, Japan

View all

Tweets

握ったままです。@nigittamamadesu·

DART臨床試験の結果から、イピリムマブとニボルマブの併用が高悪性度患者に有益である可能性があることが示された https://t.co/FtZnus3Xa9

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Thank you for requesting our ‘Sponsorship opportunities’ pack

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Researchers identify a novel way to target chemo-resistance leukaemia cells – an interview with Peter Stern

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

US FDA grant approval of pembrolizumab for advanced head & neck cancer

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Login

Uncategorized

Must read

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Thank you for requesting our ‘Sponsorship opportunities’ pack

Must watch

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Tamoxifen, SERMs and sustainable medicine

Seven challenges in immuno-oncology

The importance of a multidisciplinary team in the care of head and neck cancer

Researchers identify a novel way to target chemo-resistance leukaemia cells – an interview with Peter Stern

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

US FDA grant approval of pembrolizumab for advanced head & neck cancer

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Stay up to date

Oncology Central Newsletter